The DOI matches its Crossref record; 258 of the 259 references it cites were found in a registry or an index.
G-Protein–Coupled Receptors in Heart Disease
Open accessAbstract
GPCRs (G-protein [guanine nucleotide-binding protein]–coupled receptors) play a central physiological role in the regulation of cardiac function in both health and disease and thus represent one of the largest class of surface receptors targeted by drugs. Several antagonists of GPCRs, such as βARs (β-adrenergic receptors) and Ang II (angiotensin II) receptors, are now considered standard of therapy for a wide range of cardiovascular disease, such as hypertension, coronary artery disease, and heart failure. Although the mechanism of action for GPCRs was thought to be largely worked out in the 80s and 90s, recent discoveries have brought to the fore new and previously unappreciated mechanisms for GPCR activation and subsequent downstream signaling. In this review, we focus on GPCRs most relevant to the cardiovascular system and discuss traditional components of GPCR signaling and highlight evolving concepts in the field, such as ligand bias, β-arrestin–mediated signaling, and conformational heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenergic receptors are crucially involved in heart disease147 and platelet function148.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–258 of 258
Relaxin in cardiovascular and renal disease
Samuel, C. S., & Hewitson, T. D. (2006) · Kidney International · doi:10.1038/sj.ki.5000264 · Cited by 57
β-Arrestin mediates the Frank–Starling mechanism of cardiac contractility
Abraham, D., Davis, R. T., Warren, C. M., Mao, L., Wolska, B. M., Solaro, R. J., & Rockman, H. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609308113 · Cited by 57
Self-citationTadevosyan, A., Xiao, J., Surinkaew, S., Naud, P., Merlen, C., Harada, M., Qi, X., Chatenet, D., Fournier, A., Allen, B. G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004965 · Cited by 57
Monassier, L., Laplante, M., Jaffré, F., Bousquet, P., Maroteaux, L., & de Champlain, J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105551 · Cited by 56
The emerging roles of β-arrestins in fibrotic diseases
Gu, Y.-J., Sun, W., Zhang, S., Wu, J., & Wei, W. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.74 · Cited by 56
Shi, Q., Li, M., Mika, D., Fu, Q., Kim, S., Phan, J., Shen, A., Vandecasteele, G., & Xiang, Y. K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx036 · Cited by 54
Adverse Reactions with ??-Adrenoceptor Blocking Drugs An Update
Lewis, R. V., & Lofthouse, C. (1993) · Drug Safety · doi:10.2165/00002018-199309040-00005 · Cited by 52
Demonstration of functional M3‐muscarinic receptors in ventricular cardiomyocytes of adult rats
Pönicke, K., Heinroth‐Hoffmann, I., & Brodde, O. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704997 · Cited by 52
Cardioprotective Signaling by Endothelin
Schorlemmer, A., Matter, M. L., & Shohet, R. V. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.005 · Cited by 52
Morooka, H., Iwanaga, Y., Tamaki, Y., Takase, T., Akahoshi, Y., Nakano, Y., Fujiki, H., & Miyazaki, S. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965392 · Cited by 52
Cohn, J. N. (1993) · PubMed · Cited by 51
Cottingham, C., Chen, Y., Jiao, K., & Wang, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261578 · Cited by 51
Nijmeijer, S., Vischer, H. F., Rosethorne, E. M., Charlton, S. J., & Leurs, R. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080911 · Cited by 51
Arginine vasopressin receptor signaling and functional outcomes in heart failure
Wasilewski, M. A., Myers, V. D., Recchia, F. A., Feldman, A. M., & Tilley, D. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.021 · Cited by 50
Baltos, J., Vecchio, E. A., Harris, M. A., Qin, C. X., Ritchie, R. H., Christopoulos, A., White, P. J., & May, L. T. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.014 · Cited by 50
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development
Clay, H., Wilsbacher, L. D., Wilson, S. J., Duong, D. N., McDonald, M., Lam, I., Park, K. E., Chun, J. J. M., & Coughlin, S. R. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.024 · Cited by 49
Wang, J., Hanada, K., Gareri, C., & Rockman, H. A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26552 · Cited by 49
Self-citationSelective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate
Sensken, S.-C., Stäubert, C., Keul, P., Levkau, B., Schöneberg, T., & Gräler, M. H. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.019 · Cited by 48
Pronin, A. N., Wang, Q., & Slepak, V. Z. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109678 · Cited by 46
Teerlink, J. R., Iragui, V. J., Mohr, J. P., Carson, P. E., Hauptman, P. J., Lovett, D. H., Miller, A. B., Piña, I. L., Thomson, S. C., Varosy, P. D., et al. (2012) · Drug Safety · doi:10.2165/11594680-000000000-00000 · Cited by 45
Muscarinic receptors in the failing human heart
Giessler, C., Dhein, S., Pönicke, K., & Brodde, O. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00261-7 · Cited by 43
Puhl, S., Kazakov, A., Müller, A., Fries, P., Wagner, D. R., Böhm, M., Maack, C., & Devaux, Y. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13339 · Cited by 43
Schena, M., MULATERO, P., SCHIAVONE, D., MENGOZZI, G., TESIO, L., CHIANDUSSI, L., & VEGLIO, F. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00254-4 · Cited by 43
Abnormal Myocardial Contraction in α1A– and α1B–adrenoceptor double-knockout mice
McCloskey, D. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00227-x · Cited by 41
Tilley, D. G., Zhu, W., Myers, V. D., Barr, L. A., Gao, E., Li, X., Song, J., Carter, R. L., Makarewich, C. A., Yu, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.010434 · Cited by 41
Scalia, R. G., Gong, Y., Berzins, B., Freund, B. E., Feather, D., Landesberg, G. P., & Mishra, G. (2011) · Circulation Research · doi:10.1161/circresaha.110.229393 · Cited by 41
Kishi, T., Hirooka, Y., Konno, S., & Sunagawa, K. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328355860e · Cited by 41
GPCR biased ligands as novel heart failure therapeutics
Violin, J. D., Soergel, D. G., Boerrigter, G., Burnett, J. C. J., & Lark, M. W. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.01.002 · Cited by 40
Voors, A. A., Düngen, H., Senni, M., Nodari, S., Agostoni, P., Ponikowski, P. P., Bax, J. J., Butler, J., Kim, R. J., Dorhout, B., et al. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.828 · Cited by 40
Vasudevan, N. T., Mohan, M. L., Gupta, M. K., Martelli, E. E., Hussain, A. K., Qin, Y., Chandrasekharan, U. M., Young, D., Feldman, A. M., Sen, S., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003183 · Cited by 39
Magnan, R., Escrieut, C., Gigoux, V., De, K., Clerc, P., Niu, F., Azéma, J., Masri, B., Cordomí, A., Baltas, M., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja308784w · Cited by 38
Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells
Jensen, B. C., Swigart, P. M., Montgomery, M. D., & Simpson, P. C. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0558-x · Cited by 38
FStewart, A., GRokosh, D., ABailey, B., RKarns, L., CChang, K., SLong, C., KKariya, & CSimpson, P. (1994) · Circulation Research · Cited by 37
Adenosine receptors: protein and gene structure.
Me, O., Ren, H., & Gl, S. (1995) · PubMed · Cited by 36
Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Matera, C., & Tata, A. M. (2014) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889809666141120131238 · Cited by 35
Serotonin 5-HT 2B Receptor in Cardiac Fibroblast Contributes to Cardiac Hypertrophy
Shyu, K. (2008) · Circulation Research · doi:10.1161/circresaha.108.191122 · Cited by 31
Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways
Maguire, J. J., Kuc, R. E., Pell, V. R., Green, A. R., Brown, M., Kumar, S., Wehrman, T. S., Quinn, E. R., & Davenport, A. P. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.03.021 · Cited by 30
Heart Disease and Relaxin: New Actions for an Old Hormone
Devarakonda, T., & Salloum, F. N. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.02.008 · Cited by 30
Grandoch, M., Hoffmann, J., Roeck, K., Wenzel, F., Oberhuber, A., Schelzig, H., & Fischer, J. W. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0340-6 · Cited by 29
Felix, S. B., Baumann, G., Helmus, S., & Sattelberger, U. (1988) · Basic Research in Cardiology · doi:10.1007/bf01906682 · Cited by 29
Cardioprotective effect of histamine H2 antagonists in congestive heart failure
Zhang, J., Cai, W.-K., Zhang, Z., Wang, P., Lin, X., Ju, F., Fu, S., & He, G. (2018) · Medicine · doi:10.1097/md.0000000000010409 · Cited by 28
Endocardial endothelial celsl stimulate proliferation and collagen synthesis of cardiac fibroblasts
Kuruvilla, L., Nair, R. R., Ramachandra, U. P., Lal, V., & Kartha, C. S. (2007) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:47:1:65 · Cited by 26
Mechanosensing and Regulation of Cardiac Function
Dostal, D. E. (2014) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000314 · Cited by 26
Histamine H2-Receptor-Mediated Nitric Oxide Release from Porcine Endothelial Cells
Kishi, F., Nakaya, Y., & Ito, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199808000-00002 · Cited by 26
Gottlieb, S. S., Givertz, M. M., Metra, M., Gergich, K., Bird, S. R., Jones-Burton, C., Massie, B. M., Cotter, G., Ponikowski, P. P., Davison, B. A., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.006 · Cited by 25
Watson, L. J., Alexander, K. M., Mohan, M. L., Bowman, A. L., Mangmool, S., Xiao, K., Prasad, S. V. N., & Rockman, H. A. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.006 · Cited by 25
Self-citationChuo, C. H., Devine, S. M., Scammells, P. J., Krum, H., Christopoulos, A., May, L. T., White, P. J., & Wang, B. H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12616 · Cited by 25
Funabiki, K., Onishi, K., Dohi, K., Koji, T., Imanaka‐Yoshida, K., Ito, M., Wada, H., Isaka, N., Nobori, T., & Nakano, T. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00462.2004 · Cited by 24
Hussain, R. I., Qvigstad, E., Birkeland, J. A. K., Eikemo, H., Glende, A., Sjaastad, I., Skomedal, T., Osnes, J.-B., Levy, F. O., & Krobert, K. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1750-3639.2009.00016.x · Cited by 23
Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension
Ho, M., Low, L. M., & Rose’Meyer, R. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150021 · Cited by 23
Signal transduction mechanism of biased ligands at histamine H2 receptors
Alonso, N., Monczor, F., Echeverría, E., Davio, C. A., Shayo, C., & Fernández, N. (2014) · Biochemical Journal · doi:10.1042/bj20131226 · Cited by 22
Lee, K. Y., & Choi, H. C. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.07.007 · Cited by 20
Regulation of Human Vascular Smooth Muscle Cell Migration by β-Adrenergic Receptors
Johnson, R., Webb, J. G., Newman, W. H., & Wang, Z. (2006) · The American Surgeon · doi:10.1177/000313480607200112 · Cited by 20
Regulation of human vascular smooth muscle cell migration by beta-adrenergic receptors.
Johnson, R., Webb, J. G., Newman, W. H., & Wang, Z. (2006) · PubMed · Cited by 19
β-Adrenergic Receptor Subtype Signaling in the Heart: from Bench to the Bedside
Zhu, W., Woo, A. Y., Zhang, Y., Cao, C., & Xiao, R. (2011) · Current topics in membranes · doi:10.1016/b978-0-12-384921-2.00009-4 · Cited by 18
Green, D. S., Rupasinghe, C. N., Warburton, R. R., Wilson, J. L., Sallum, C. O., Taylor, L., Yatawara, A. K., Mierke, D. F., POLGAR, P. R., & Hill, N. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081309 · Cited by 15
Zhao, M. F., Jia, H.-H., Liu, L., Bi, X., Xu, M., Yu, X., He, X., & Zang, W. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.04.001 · Cited by 11
Shogakiuchi, Y., Kanaide, H., & Nakamura, M. (1991) · Circulation Research · doi:10.1161/01.res.68.3.818 · Cited by 6
Research works printed but not linked: 1
- 10.1016/S0895-7061(00)86965-4 · DOI
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, K., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 540
G Protein-Coupled Receptors: A Century of Research and Discovery
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 196
Self-citationCardiac Fibrosis and Fibroblasts
Kurose, H. (2021) · Cells · doi:10.3390/cells10071716 · Cited by 178
A Global Map of G Protein Signaling Regulation by RGS Proteins
Masuho, I., Santhanam, B., Muntean, B. S., Skamangas, N. K., Chavali, S., Tesmer, J. J. G., Babu, M. M., & Martemyanov, K. A. (2020) · Cell · doi:10.1016/j.cell.2020.08.052 · Cited by 167
Metadata
- Authors
- Wang, J., Gareri, C., & Rockman, H. A.
- Affiliations
- From the Department of Medicine (J.W., C.G., H.A.R.)
- Duke University (US)
- Venue
- Circulation Research
- Published
- 2018-08-31
- Volume
- 123
- Issue
- 6
- Pages
- 716-735
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC6205195
- OpenAlex
- W2889986213
- Cited by
- 303
- References
- 259
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 57 · 2023: 49 · 2022: 47 · 2021: 45 · 2020: 31 · 2019: 14
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-10-25)
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL075443, R01HL056687)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- G protein-coupled receptors, heart disease, cardiac function, beta-adrenergic receptors, angiotensin II receptor, G protein-coupled receptor signaling, ligand bias, β-arrestin signaling, conformational heterogeneity, heart failure, hypertension, coronary artery disease, cardiovascular drug targets
- MeSH terms
- Animals, Cardiovascular Agents, Fibroblasts, Heart Failure, Heart Ventricles, Humans, Signal Transduction, Ventricular Function, Ventricular Remodeling, Myocytes, Cardiac, Myocytes, Smooth Muscle, Endothelial Cells, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review